Articles

New Collaboration Opportunities In Regenerative Medicine

New Collaboration Opportunities in Regenerative Medicine and Addressing Challenges to Clinical Adoption of Cell and Gene Therapies New Hunts House Guy’s campus King’s College...

£30,000 to identify key research challenges in Regenerative Device Development

Call for submissions: Crowdsourcing competition £30,000 to identify key research challenges in Regenerative Device Development About this competition The Medical...

Minister joins ReNeuron Board on tour of their new premises

Economy Minister Edwina Hart joined the ReNeuron Board this week on a tour of their new premises at the Welsh Government’s state-of-the-art Advanced Therapy Medical Productions manufacturing...

Cobra & CPI to Collaborate on Regenerative Medicine

Cobra Biologics and Centre for Process Innovation Announce Collaboration to Advance Development of Regenerative Medicines  Cobra Biologics Ltd (Cobra), international CDMO of biologics...

Would you like to present at Regener8 2016?

“Building the Regenerative Devices Industry” – Friday 1 July 2016, Leeds Regener8 and the Medical Technologies IKC are to host a one-day conference, focussing on best practice in translating...

UK companies advance development of regenerative medicines and cell therapies

With the 2015 competition ‘ Developing Regenerative Medicines and Cell Therapies’ , Innovate UK will invest up to £8 million in collaborative R&D projects that address critical challenges...

The Inaugural UK Regenerative Medicine Conference

The Inaugural UK  Regenerative Medicine Conference Venue:   RIBA  66 Portland Place, London W1B 1AD   The  Cell Therapy Catapult  and  UK...

UK Regenerative Medicine Platform Annual Report 2015

2015 Annual Report of the UK Regenerative Medicine Platform (UKRMP). The BBSRC, EPSRC and the MRC have jointly invested £25M to establish the UKRMP to tackle the technical and scientific...

BIA Briefing Paper: Advanced Therapy Medicinal Products and Regenerative Medicine

The BIA has launched a new briefing paper on Advanced Therapy Medicinal Products (ATMPs) at the Alliance for Regenerative Medicine European Investor Day in London. The briefing paper reveals a...

Biomedical Catalyst: Regenerative Medicine Research Committee

Status: Open Open date: 06/10/2015 Closing date: 17/11/2015 16:00 Type: Calls Categories:  Molecular and cellular medicine , ...

Graphene Biomedical Application Workshop Series

Graphene Biomedical Application Workshop Series Manchester – 7 th October 2015 The NGI is organizing an industry-focus workshop on biomedical applications of graphene in different...

Materials for demanding environments : cross-sector opportunity

Innovate UK is to invest up to £2 million in technical feasibility studies to explore improving the performance of materials in demanding, extreme and/or aggressive environments.   ...

Boost for UK medical technology innovation

The University of Leeds Medical Technologies Innovation and Knowledge Centre (IKC) has won £3 million to continue bringing the best of the UK’s medical technology research to patients. The...

UK Cell Therapy GMP Manufacturing Capacity and Capability Increases

The Cell Therapy Catapult has published its annual survey of the GMP licensed cell and gene manufacturing capability and capacity in the UK, which shows growth in the cell therapy industry to...

11th Technical Meeting of the Advanced Therapy Medicinal Product (ATMP) Manufacturing Community (amc)

Thursday 24th September 2015, 9.30am - 6pm at the National Biologics Manufacturing Centre, 1 Union Square, Central Park, Darlington, DL1 1GL Focused on moving towards closed processing for...

Innovate UK’s Regen Med Funding Competition Closing soon! Last Chance to Register 26th August

Click  here  for full scope and details. Contact  sarah.goulding@ktn-uk.org  if as a company you would like KTN support with your application

Immunomodulation of Stem Cells 2015

Leaders representing industry and academia will discuss the impact of the immune system in regenerative medicine. This workshop will provide a platform for international oversight and...

Immunocore secures $320 million (£205 million) in Europe’s Largest Private Life Sciences Financing

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today announced...

Funding Call information presentations available

Presentations are now available from 'Accessing the Innovation Landscape for Regenerative Medicine and Cell Therapies’. Over 100 people attended the event in London on 15th July, to hear more...

LAST CHANCE TO REGISTER: Accessing the UK’s Innovation Landscape for Regenerative Medicine and Cell Therapies

  Accessing the UK’s Innovation Landscape for Regenerative Medicine and Cell Therapies  Funding opportunities and translational R&D support capabilities 15 th ...
Showing 1 - 20 of 45 results.
Items per Page 20
of 3

     

Get updates on the latest health community news, events, funding opportunities and more.

You can now join us on LinkedIn